Cartesian Therapeutics Inc
NASDAQ:RNAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
X
|
Xencor Inc
F:XE9
|
US |
|
Hasbro Inc
NASDAQ:HAS
|
US |
|
C
|
Canopy Holdings AS
OSE:CAN
|
NO |
Wall Street
Price Targets
RNAC Price Targets Summary
Cartesian Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
RNAC
is 36.28 USD
with a low forecast of 16.16 USD and a high forecast of 46.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RNAC's stock price target?
Price Target
36.28
USD
According to Wall Street analysts, the average 1-year price target for
RNAC
is 36.28 USD
with a low forecast of 16.16 USD and a high forecast of 46.2 USD.
What is Cartesian Therapeutics Inc's Revenue forecast?
Projected CAGR
112%
For the last 10 years the
compound annual growth rate for
Cartesian Therapeutics Inc's revenue is
-7%.
The projected
CAGR
for the next 3 years is
112%.
